MétaCan
Menu
Back to cohort
Record W4415601405 · doi:10.14740/aicm5

Generative Artificial Intelligence as a Catalyst for Effective Cancer Treatments

2025· article· en· W4415601405 on OpenAlexaff
Youcef Derbal

Bibliographic record

VenueAI in Clinical Medicine · 2025
Typearticle
Languageen
FieldMedicine
TopicArtificial Intelligence in Healthcare and Education
Canadian institutionsToronto Metropolitan University
Fundersnot available
KeywordsCancerImmunotherapyPrecision medicineDiseaseCancer immunotherapyCancer therapyCancer treatment

Abstract

fetched live from OpenAlex

Current standard of cancer care is supported by a continuously expanding set of therapeutic options becoming available to cancer patients such as KRAS inhibitors, third-generation tyrosine kinase inhibitors (e.g., osimertinib), new immunotherapy drugs (e.g., durvalumab), as well as adaptive and combination therapies involving chemotherapy, radiotherapy, immunotherapy and targeted therapy. Despite these advances, therapeutic resistance persists as an inevitable challenge to cancer cure. While combination therapy is a plausible strategy to thwart therapeutic resistance, further research is needed on rationalizing drug combinations. On the other hand, adaptive therapy is emerging as a sound strategy to counter the evolving nature of cancer and thwart or delay the onset of therapeutic resistance. Indeed, cancer is a nonlinear time-varying dynamical system whose treatment can be viewed as a problem of steering the disease to a desired end-state of cure or stable management based on monitored treatment response. The success of this strategy depends on accurate and reliable estimations/predictions of disease state and tumor growth dynamics. Therein lies the potential of generative artificial intelligence (GenAI) and its underlying large language models (LLMs) to leverage the accumulating big clinical, radiomic and molecular data about cancer patients and their treatments to power its learning and predictive capabilities towards assisting treatment decision-making. This perspective starts with examples of current therapeutic advances and a succinct overview of persisting challenges to the development of effective cancer treatments, followed by a broad survey of artificial intelligence (AI) applications in oncology and their varying degrees of clinical readiness. Given this context, cancer treatment is framed as a problem of controlling a nonlinear time-varying dynamical system, where data-driven GenAI learning and predictive capabilities would be instrumental in resolving the challenges of disease monitoring and controllability. The perspective shares insights about potential pathways to GenAI-assisted improvement of cancer treatments and discusses key challenges to its deployment in real-world clinical settings, including data curation, clinical validation, LLM hallucinations and ethical concerns. Ultimately, advancing noninvasive tracking of treatment response dynamics and curating corresponding big LLM training datasets are essential to the potential of GenAI as a catalyst for effective cancer treatments.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame distilled prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. Learned from the 10,348 direct Codex labels and 10,348 direct Gemma labels. Candidate is the union of thresholded teacher heads; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels or direct frontier model labels.

metaresearch head score (Codex)0.001
metaresearch head score (Gemma)0.006
Version: codex-gemma-dda1882f352aValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Other design · Consensus signal: none
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.946
Threshold uncertainty score0.702

Codex and Gemma teacher scores by category

CategoryCodexGemma
Metaresearch0.0010.006
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0010.000
Bibliometrics0.0000.001
Science and technology studies0.0000.000
Scholarly communication0.0000.000
Open science0.0000.000
Research integrity0.0000.000
Insufficient payload (model declined to judge)0.0000.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.304
GPT teacher head0.612
Teacher spread0.309 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one teacher head, not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designOther design
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations2
Published2025
Admission routes1
Has abstractyes

Explore more

Same venueAI in Clinical MedicineSame topicArtificial Intelligence in Healthcare and EducationFrench-language works237,207